Skip to content

Drug interactions

Fedratinib + Selegiline

Severity: Minor

Fedratinib and Selegiline: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is metabolized by CYP3A4, CYP2C19 and CYP2C9, and selegiline is a weak inhibitor of some of these enzymes at most. The clinical effect on fedratinib exposure has not been established and is likely small.

What this interaction means in plain words

Fedratinib and Selegiline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fedratinib belongs to Oncology; Selegiline belongs to Central Nervous System.

Evidence level: Low

Why it happens

Possible weak CYP inhibition by selegiline; mechanism not clearly established.

What to do

No dose adjustment is established. Monitor for fedratinib toxicity such as gastrointestinal effects and cytopenias.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Selegiline, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Selegiline?

MediHelp rates the interaction as minor. Fedratinib and Selegiline have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fedratinib is metabolized by CYP3A4, CYP2C19 and CYP2C9, and selegiline is a weak inhibitor of some of these enzymes at most. The clinical effect on fedratinib exposure has not been established and is likely small.

How serious is the interaction between Fedratinib and Selegiline?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is established. Monitor for fedratinib toxicity such as gastrointestinal effects and cytopenias.

What other medicines interact with Selegiline?

MediHelp also lists interactions of Selegiline with, for example, Amitriptyline, Amoxapine, Atomoxetine. The full list is on the Selegiline page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in